Spots Global Cancer Trial Database for vatalanib
Every month we try and update this database with for vatalanib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors | NCT00390000 | Unspecified Adu... | vatalanib pemetrexed diso... pharmacological... ultrasound imag... | 18 Years - | Mayo Clinic | |
| Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer | NCT00293371 | Prostate Cancer | docetaxel prednisone vatalanib | 18 Years - | University of California, San Francisco | |
| Vatalanib in Treating Patients With Recurrent or Progressive Meningioma | NCT00348790 | Brain and Centr... Sarcoma | vatalanib | 18 Years - | Northwestern University | |
| Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | NCT00227773 | Gastrointestina... Islet Cell Carc... | octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00128700 | Brain and Centr... | temozolomide vatalanib adjuvant therap... radiation thera... | 18 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors | NCT00590343 | Metastatic Neur... | vatalanib | 18 Years - | Louisiana State University Health Sciences Center in New Orleans | |
| Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer | NCT00185588 | Pancreatic Canc... | Vatalanib Gemcitabine | 18 Years - | Stanford University | |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer | NCT00056446 | Colorectal Neop... Colonic Neoplas... Rectal Neoplasm... | Vatalanib | 18 Years - | Novartis | |
| Vatalanib in Treating Patients With Recurrent or Progressive Meningioma | NCT00348790 | Brain and Centr... Sarcoma | vatalanib | 18 Years - | Northwestern University | |
| Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma | NCT00387933 | Brain and Centr... | hydroxyurea imatinib mesyla... vatalanib | 18 Years - | Duke University | |
| Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | NCT00227773 | Gastrointestina... Islet Cell Carc... | octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma | NCT00387933 | Brain and Centr... | hydroxyurea imatinib mesyla... vatalanib | 18 Years - | Duke University | |
| Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors | NCT00590343 | Metastatic Neur... | vatalanib | 18 Years - | Louisiana State University Health Sciences Center in New Orleans | |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. | NCT00056459 | Colorectal Neop... Colonic Neoplas... Rectal Neoplasm... | Vatalanib | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
